Target Discovery and Validation Reviews and Protocols

Immunoproteomics 333
3. 2D-PAGE is usually performed in reducing conditions, which may be an issue for
detection of certain antigens for which epitope(s) involving disulfide bonds would
be lost.
References
1. Happ, S. S. (1997) A Commotion in the Blood: Life, Death, and the Immune
System. The Spoon Technology Series. Henry Holt and Company Inc., NY, NY.
2. Jager, E., Chen, Y. T., Drijfhout, J. W., et al. (1998) Simultaneous humoral and
cellular immune response against cancer-testis antigen NY-ESO-1: definition of
human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
J. Exp. Med. 187, 265–270.
3. Jager, D., Jager, E., and Knuth, A. (2001) Vaccination for malignant melanoma:
recent developments. Oncology 60, 1–7.
4. Nakatsura, T., Senju, S., Ito, M., Nishimura, Y., and Itoh, K. (2002) Cellular and
humoral immune responses to a human pancreatic cancer antigen, coactosinlike
protein, originally defined by the SEREX method. Eur. J. Immunol. 32,
826–836.
5. van der Bruggen, P., Traversari, C., Chomez, P., et al. (1991) A gene encoding an
antigen recognized by cytolytic T lymphocytes on a human melanoma. Science
254, 1643–1647.
6. Renkvist, N., Castelli, C., Robbins, P. F., and Parmiani, G. (2001) A listing of human
tumor antigens recognized by T cells. Cancer Immunol. Immunother. 50, 3–15.
7. Sahin, U., Türeci, O., Schmitt, H., et al. (1995) Human neoplasms elicit multiple
specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92,
11,810–11,813.
8. Old, L. J. and Chen, Y. T. (1998) New paths in human cancer serology. J. Exp.
Med. 187, 1163–1167.
9. Türeci, O., Sahin, U., Zwick, C., Neumann, F., and Pfreundschuh M. (1999)
Exploitation of the antibody repertoire of cancer patients for the identification of
human tumor antigens. Hybridoma 18, 23–28.
10. Chen, Y. T. (2000) Cancer vaccine: identification of human tumor antigens by
SEREX. Cancer J. Sci. Am. 6, s208–s217.
11. Nishikawa, H., Tanida, K., Ikeda, H., et al. (2001) Role of SEREX-defined
immunogenic wild-type cellular molecules in the development of tumor-specific
immunity. Proc. Natl. Acad. Sci. USA 98, 14,571–14,576.
12. Patterson, S. D. and Aebersold, R. H. (2003) Proteomics: the first decade and
beyond. Nat. Genet. 33, Suppl, 311–323.
13. Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S., and Mische, S. M.
(1999) Mass spectrometric identification of proteins from silver-stained
polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity.
Electrophoresis 20, 601–605.
14. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric
sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68,
850–858.